High Flow Nasal Cannula Weaning in Acute Bronchiolitis
Recruiting
N/A
Interventional Study
Acute Bronchiolitis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 0 Months – 12 Months
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 50 (estimated)
- Sponsor
- Kuopio University Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical study is to compared two different strategies to end high flow nasal cannula treatment in acute bronchiolitis. This study compared the immediate ending of high flow treatment to weaning strategy, in which the flow rate is gradually decreased. The aim is to assess if the immediate ending shortens the hospitalization time and whether it is a safe strategy.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Clinically diagnosed acute bronchiolitis
* High flow nasal cannula treatment has lasted for at least 12 hours
* Measured saturation 95 or more with room air
* High flow rate is maximum 2l/kg/min
* The treating doctors considers the infant suitable to be without high flow
Excl…
Contacts